The SpHb tracked changes in hemoglobin satisfactorily during surgery and more accurately estimated the appropriate timing for invasive hemoglobin measurements.
The FDA has not granted marketing authorization for any robotically-assisted surgical devices for use in mastectomy or for treatment or prevention of cancer.